31 related articles for article (PubMed ID: 38554799)
1. Secondary Neovascular Glaucoma in the Course of Diabetes in a Kidney Transplant Recipient: Case Report and Review of the Literature.
Janicka Z; Storoniak H; Konopa J; Ślizień M; Gębka A; Michalska-Małecka K; Dębska-Ślizień A
Transplant Proc; 2024 May; 56(4):981-987. PubMed ID: 38658247
[TBL] [Abstract][Full Text] [Related]
2. Proteomic changes of aqueous humor in proliferative diabetic retinopathy patients treated with different intravitreal anti-VEGF agents.
Chen H; Qiu B; Gao G; Chen Y; Min H; Wu Z
Exp Eye Res; 2022 Mar; 216():108942. PubMed ID: 35032522
[TBL] [Abstract][Full Text] [Related]
3. Angiogenic and inflammatory biomarker levels in aqueous humor and vitreous of neovascular glaucoma and proliferative diabetic retinopathy.
Sun C; Zhang H; Jiang J; Li Y; Nie C; Gu J; Luo L; Wang Z
Int Ophthalmol; 2020 Feb; 40(2):467-475. PubMed ID: 31802372
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of angiogenic factors in aqueous humor associated with less intraoperative bleeding in PDR patients with NVG receiving conbercept: a randomized controlled trial.
Xu Q; Gong C; Qiao L; Feng R; Liu H; Liu Y; Yang L; Fan W; Guan L; Li J; Zhang Y; Li S
BMC Ophthalmol; 2022 May; 22(1):224. PubMed ID: 35585570
[TBL] [Abstract][Full Text] [Related]
5. Aqueous Inflammation and Ischemia-Related Biomarkers in Neovascular Glaucoma with Stable Iris Neovascularization.
Sun C; Zhang H; Tang Y; Chen Y; Li Y; Nie C; Gu J; Luo L; Wang Z
Curr Eye Res; 2020 Dec; 45(12):1504-1513. PubMed ID: 32339463
[No Abstract] [Full Text] [Related]
6. What is the impact of intravitreal injection of conbercept on neovascular glaucoma patients: a prospective, interventional case series study.
Shi L; Yang J; Lin J
BMC Ophthalmol; 2019 Jun; 19(1):128. PubMed ID: 31185956
[TBL] [Abstract][Full Text] [Related]
7. Analysis aqueous humor lipid profile of neovascular glaucoma secondary to diabetic retinopathy and lipidomic alteration response to anti-VEGF treatment.
Wang X; Ma X; Song J; Liu B; Wang J
Exp Eye Res; 2024 May; 242():109878. PubMed ID: 38554799
[TBL] [Abstract][Full Text] [Related]
8. A review of neovascular glaucoma. Etiopathogenesis and treatment.
Dumbrăveanu L; Cușnir V; Bobescu D
Rom J Ophthalmol; 2021; 65(4):315-329. PubMed ID: 35087972
[TBL] [Abstract][Full Text] [Related]
9. Updates on the Management of Ocular Vasculopathies with VEGF Inhibitor Conbercept.
Liu H; Ma Y; Xu HC; Huang LY; Zhai LY; Zhang XR
Curr Eye Res; 2020 Dec; 45(12):1467-1476. PubMed ID: 32631094
[No Abstract] [Full Text] [Related]
10. Anti-vascular endothelial growth factor for neovascular glaucoma.
Simha A; Aziz K; Braganza A; Abraham L; Samuel P; Lindsley KB
Cochrane Database Syst Rev; 2020 Feb; 2(2):CD007920. PubMed ID: 32027392
[TBL] [Abstract][Full Text] [Related]
11. Anti-vascular endothelial growth factor for neovascular glaucoma.
Rittiphairoj T; Roberti G; Michelessi M
Cochrane Database Syst Rev; 2023 Apr; 4(4):CD007920. PubMed ID: 37010901
[TBL] [Abstract][Full Text] [Related]
12. Angiogenesis in glaucoma filtration surgery and neovascular glaucoma: A review.
Kim M; Lee C; Payne R; Yue BY; Chang JH; Ying H
Surv Ophthalmol; 2015; 60(6):524-35. PubMed ID: 25980779
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
